Elective Percutaneous Coronary Intervention in Ambulatory Surgery Centers

被引:6
作者
Li, Kevin [1 ]
Kalwani, Neil M. [2 ]
Heidenreich, Paul A. [2 ]
Fearon, William F. [2 ]
机构
[1] Stanford Univ, Dept Med, Stanford, CA 94305 USA
[2] Stanford Univ, Dept Med, Stanford Cardiovasc Inst, Div Cardiovasc Med, 300 Pasteur Dr,H2103, Stanford, CA 94305 USA
基金
美国国家卫生研究院;
关键词
ischemic heart disease; outcomes; PCI; percutaneous coronary intervention; health services research; SAME-DAY DISCHARGE; TEMPORAL TRENDS; ANGIOGRAPHY; MORTALITY; OUTCOMES; ACCESS; IMPACT; RISK; SITE;
D O I
10.1016/j.jcin.2020.10.015
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES The aim of this study was to explore characteristics and outcomes of patients undergoing elective percutaneous coronary intervention (PCI) in ambulatory surgery centers (ASCs). BACKGROUND Little is known about patients who underwent ASC PCI before Medicare reimbursement was instituted in 2020. METHODS Using commercial insurance claims from MarketScan, adults who underwent hospital outpatient department (HOPD) or ASC PCI for stable ischemic heart disease from 2007 to 2016 were studied. Propensity score analysis was used to measure the association between treatment setting and the primary composite outcome of 30-day myocardial infarction, bleeding complications, and hospital admission. RESULTS The unmatched sample consisted of 95,492 HOPD and 849 ASC PCIs. Patients who underwent ASC PCI were more likely to be younger than 65 years, to live in the southern United States, and to have managed or consumer-driven health insurance. ASC PCI was also associated with decreased fractional flow reserve utilization (odds ratio [OR]: 0.31; 95% confidence interval [CI]: 0.20 to 0.48; p < 0.001). In unmatched, multivariate analysis, ASC PCI was associated with increased odds of the primary outcome (OR: 1.25; 95% CI: 1.01 to 1.56; p = 0.039) and bleeding complications (OR: 1.80; 95% CI: 1.11 to 2.90; p = 0.016). In propensity-matched analysis, ASC PCI was not associated with the primary outcome (OR: 1.23; 95% CI: 0.94 to 1.60; p = 0.124) but was significantly associated with increased bleeding complications (OR: 2.49; 95% CI: 1.25 to 4.95; p = 0.009). CONCLUSIONS Commercially insured patients undergoing ASC PCI were less likely to undergo fractional flow reserve testing and had higher odds of bleeding complications than HOPD-treated patients. Further study is warranted as Medicare ASC PCI volume increases. (J Am Coll Cardiol Intv 2021;14:292-300) Published by Elsevier on behalf of the American College of Cardiology Foundation
引用
收藏
页码:292 / 300
页数:9
相关论文
共 50 条
  • [21] Safety of same day discharge following percutaneous coronary intervention
    Herman, Brian A.
    HEART LUNG AND CIRCULATION, 2011, 20 (06) : 353 - 356
  • [22] Predictors of angina resolution after percutaneous coronary intervention in stable coronary artery disease
    Verreault-Julien, Louis
    Bhatt, Deepak L.
    Jung, Richard G.
    Di Santo, Pietro
    Simard, Trevor
    Avram, Robert
    Hibbert, Benjamin
    CORONARY ARTERY DISEASE, 2022, 33 (02) : 98 - 104
  • [23] Overlap in Age at the Time of Elective Percutaneous Coronary Intervention and at Noncardiac Surgery
    Smilowitz, Nathaniel R.
    Berger, Jeffrey S.
    Beckman, Joshua A.
    Bangalore, Sripal
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (13) : 1554 - 1555
  • [24] Clinical Significance of Coronary Flow Reserve Improvement After Elective Percutaneous Coronary Intervention
    Hanyu, Yoshihiro
    Hoshino, Masahiro
    Usui, Eisuke
    Sugiyama, Tomoyo
    Kanaji, Yoshihisa
    Hada, Masahiro
    Nagamine, Tatsuhiro
    Nogami, Kai
    Ueno, Hiroki
    Yonetsu, Taishi
    Sasano, Tetsuo
    Kakuta, Tsunekazu
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2025,
  • [25] Omega-3 Supplementation in the Prevention of Contrast Induced Nephropathy in Patients Undergoing Elective Percutaneous Coronary Intervention: A Randomized Placebo-Controlled Trial
    Foroughinia, Farzaneh
    Mirjalili, Mahtabalsadat
    Mirzaei, Ehsan
    Oboodi, Alireza
    ADVANCED PHARMACEUTICAL BULLETIN, 2019, 9 (02) : 307 - 313
  • [26] Management of Percutaneous Coronary Intervention Complications Algorithms From the 2018 and 2019 Seattle Percutaneous Coronary Intervention Complications Conference
    Doll, Jacob A.
    Hira, Ravi S.
    Kearney, Kathleen E.
    Kandzari, David E.
    Riley, Robert F.
    Marso, Steven P.
    Grantham, James A.
    Thompson, Craig A.
    McCabe, James M.
    Karmpaliotis, Dimitrios
    Kirtane, Ajay J.
    Lombardi, William
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2020, 13 (06)
  • [27] Safety of Reversing Anticoagulation by Protamine Following Elective Transfemoral Percutaneous Coronary Intervention in the Drug-Eluting Stent Era
    Yamamoto, Shingo
    Sakakura, Kenichi
    Taniguchi, Yousuke
    Yamamoto, Kei
    Wada, Hiroshi
    Momomura, Shin-ichi
    Fujita, Hideo
    INTERNATIONAL HEART JOURNAL, 2018, 59 (03) : 482 - 488
  • [28] Percutaneous coronary intervention in patients refused from surgery: a different entity?
    Montone, Rocco A.
    Niccoli, Giampaolo
    MINERVA CARDIOANGIOLOGICA, 2018, 66 (05): : 562 - 568
  • [29] Comparative effectiveness of coronary artery bypass grafting (CABG) surgery and percutaneous coronary intervention (PCI) in elderly patients with diabetes
    Shah, Ruchit
    Yang, Yi
    Bentley, John P.
    Banahan, Benjamin F., III
    CURRENT MEDICAL RESEARCH AND OPINION, 2016, 32 (11) : 1891 - 1898
  • [30] Relation of Length of Stay to Unplanned Readmissions for Patients Who Undergo Elective Percutaneous Coronary Intervention
    Kwok, Chun Shing
    Rao, Sunil V.
    Gilchrist, Ian C.
    Potts, Jessica
    Nagaraja, Vinayak
    Gunning, Mark
    Nolan, James
    Kontopantelis, Evangelos
    Bertrand, Olivier F.
    Mamas, Mamas A.
    AMERICAN JOURNAL OF CARDIOLOGY, 2019, 123 (01) : 33 - 43